What is the optimal range of glycemic control for non-diabetic patients undergoing gastroenterological surgery? A single-center randomized controlled trial using an artificial pancreas.
Nobuhisa TaniokaHiromichi MaedaSunao UemuraMasaya MunekageHiroyuki KitagawaTsutomu NamikawaHajime KuroiwaShimpei FujimotoSatoru SeoKazuhiro HanazakiPublished in: Artificial organs (2023)
Clinically relevant short-term results did not differ, implying that 80-110 and 110-140 mg/dL are permissible glycemic control ranges when using AP in non-diabetic patients undergoing gastroenterological surgery. (Registered in UMIN; UMIN000028036).
Keyphrases
- glycemic control
- type diabetes
- patients undergoing
- minimally invasive
- blood glucose
- randomized controlled trial
- coronary artery bypass
- weight loss
- insulin resistance
- wound healing
- surgical site infection
- study protocol
- transcription factor
- systematic review
- acute coronary syndrome
- metabolic syndrome
- coronary artery disease
- clinical trial
- adipose tissue
- atrial fibrillation